Aldevron Names Marc Wolff Chief Financial Officer
Marc Wolff has been named Chief Financial Officer of Aldevron, a leading global provider of plasmid DNA manufacturing, p…
Marc Wolff has been named Chief Financial Officer of Aldevron, a leading global provider of plasmid DNA manufacturing, p…
Aldevron, a global provider of contract plasmid manufacturing services for the biotechnology industry, has selected AES…
Aldevron, the world’s leading contract plasmid manufacturing organization, has announced the immediate availability of a…
Aldevron, a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, and Inte…
Thomas Lynch, Ph.D., has been named Vice President of Sales and Client Development of Aldevron, a global provider of pla…
Henry Hebel has been named Chief Operating Officer of Aldevron, a leading global provider of contract plasmid DNA manufa…
Aldevron, a leading contract manufacturing and development organization, along with the Myeloma Crowd, a non-profit foun…
Aldevron, a leading biotechnology contract manufacturing and development organization, is now using a 30-liter single-us…
Aldevron (Fargo, ND) announced today its participation in a joint research project partially funded by the German state…
Aldevron is pleased to announce its participation in a new three year, €3.9 million research project to study the long-t…